Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 159
9
Diseases
16
Unique genes
0.220
Avg. similarity score
Anodontia
Most-connected disease (7 links)
Disease
Searched: Severe neonatal spondylometaphyseal dysplasia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Severe neonatal spondylometaphyseal dysplasia
Anodontia
Wolf-hirschhorn syndrome
Tooth and nail syndrome
Witkop syndrome
tooth agenesis, selective, 1
Shwachman-diamond syndrome
Early-onset epilepsy-intellectual disability-brain anomalies syndrome
craniofacial dysplasia - osteopenia syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Anodontia | 7 | 7 | 4 |
| Wolf-hirschhorn syndrome | 5 | 5 | 7 |
| Tooth and nail syndrome | 4 | 4 | 1 |
| Witkop syndrome | 4 | 4 | 1 |
| tooth agenesis, selective, 1 | 4 | 4 | 1 |
| Severe neonatal spondylometaphyseal dysplasia | 2 | 2 | 1 |
| Shwachman-diamond syndrome | 2 | 2 | 7 |
| Early-onset epilepsy-intellectual disability-brain anomalies syndrome | 1 | 1 | 1 |
| craniofacial dysplasia - osteopenia syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MSX1 | 5 / 9 | Anodontia, tooth agenesis, selective, 1, Tooth and nail syndrome, Witkop syndrome and 1 more |
| SBDS | 3 / 9 | Anodontia, Severe neonatal spondylometaphyseal dysplasia, Shwachman-diamond syndrome |
| IRX5 | 2 / 9 | Anodontia, craniofacial dysplasia - osteopenia syndrome |
| PIGG | 2 / 9 | Early-onset epilepsy-intellectual disability-brain anomalies syndrome, Wolf-hirschhorn syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Protein export | KEGG | 3 / 31 | 72.6× | 8.52e-6 | 3.12e-4 ✓ sig. |
| Ribosome biogenesis in eukaryotes | KEGG | 3 / 125 | 18.0× | 5.58e-4 | 9.01e-3 ✓ sig. |
| SRP-dependent cotranslational protein targeting to membrane | Reactome | 2 / 93 | 16.1× | 6.63e-3 | 5.47e-2 |
| FGFRL1 modulation of FGFR1 signaling | Reactome | 1 / 13 | 57.7× | 1.72e-2 | 9.84e-2 |
| Synthesis of glycosylphosphatidylinositol (GPI) | Reactome | 1 / 17 | 44.2× | 2.24e-2 | 1.14e-1 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | Reactome | 1 / 23 | 32.6× | 3.02e-2 | 1.35e-1 |
| Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | KEGG | 1 / 30 | 25.0× | 3.93e-2 | 1.55e-1 |
| Formation of the Early Elongation Complex | Reactome | 1 / 33 | 22.7× | 4.31e-2 | 1.63e-1 |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 19.8× | 4.95e-2 | 1.76e-1 |
| XBP1(S) activates chaperone genes | Reactome | 1 / 50 | 15.0× | 6.46e-2 | 2.02e-1 |
| RNA Polymerase II Transcription Elongation | Reactome | 1 / 59 | 12.7× | 7.58e-2 | 2.20e-1 |
| Formation of RNA Pol II elongation complex | Reactome | 1 / 61 | 12.3× | 7.83e-2 | 2.24e-1 |
| Lysine degradation | KEGG | 1 / 63 | 11.9× | 8.08e-2 | 2.28e-1 |
| Viral life cycle - HIV-1 | KEGG | 1 / 64 | 11.7× | 8.20e-2 | 2.30e-1 |
| TP53 Regulates Transcription of DNA Repair Genes | Reactome | 1 / 65 | 11.5× | 8.32e-2 | 2.31e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cytosolic ribosome assembly | GO:0042256 | 3 / 5 | 701× | 5.14e-9 | 9.48e-7 ✓ sig. |
| SRP-dependent cotranslational protein targeting to membrane | GO:0006614 | 3 / 10 | 350× | 6.16e-8 | 8.14e-6 ✓ sig. |
| SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | GO:0006617 | 3 / 14 | 250× | 1.86e-7 | 2.10e-5 ✓ sig. |
| cotranslational protein targeting to membrane | GO:0006613 | 2 / 10 | 234× | 3.08e-5 | 1.29e-3 ✓ sig. |
| protein targeting to ER | GO:0045047 | 2 / 15 | 156× | 7.17e-5 | 2.44e-3 ✓ sig. |
| ribosome biogenesis | GO:0042254 | 3 / 122 | 28.7× | 1.43e-4 | 4.07e-3 ✓ sig. |
| bone morphogenesis | GO:0060349 | 2 / 32 | 73.0× | 3.36e-4 | 7.49e-3 ✓ sig. |
| negative regulation of odontoblast differentiation | GO:1901330 | 1 / 1 | 1,168× | 8.56e-4 | 1.41e-2 ✓ sig. |
| assembly of large subunit precursor of preribosome | GO:1902626 | 1 / 1 | 1,168× | 8.56e-4 | 1.41e-2 ✓ sig. |
| bone mineralization | GO:0030282 | 2 / 56 | 41.7× | 1.03e-3 | 1.59e-2 ✓ sig. |
| mitotic spindle organization | GO:0007052 | 2 / 58 | 40.3× | 1.10e-3 | 1.66e-2 ✓ sig. |
| atrial septum secundum morphogenesis | GO:0003290 | 1 / 2 | 584× | 1.71e-3 | 2.14e-2 ✓ sig. |
| cell surface receptor signaling pathway involved in heart development | GO:0061311 | 1 / 2 | 584× | 1.71e-3 | 2.14e-2 ✓ sig. |
| positive regulation of mesenchymal cell apoptotic process | GO:2001055 | 1 / 3 | 389× | 2.57e-3 | 2.69e-2 ✓ sig. |
| negative regulation of striated muscle cell differentiation | GO:0051154 | 1 / 3 | 389× | 2.57e-3 | 2.69e-2 ✓ sig. |